ClinicalTrials.gov
public full text
Public Domain
A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)
This study is designed to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of MK2206 when administered with Every Other Day (QOD) and Once Weekly (QW) dosing schedules.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)#892893
- A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)#905360
- A Study of KF-0210 in Advanced Solid Tumors Patients#968116
- A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors#855880
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.#831965
Record · ID 1088956
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive